Carotid body tumor diagnostic study of choice

	Carotid body tumor Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Carotid Body Tumor from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X-ray
Echocardiography and Ultrasound
CT scan
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Carotid body tumor diagnostic study of choice On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Carotid body tumor diagnostic study of choice All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Carotid body tumor diagnostic study of choice
CDC on Carotid body tumor diagnostic study of choice
Carotid body tumor diagnostic study of choice in the news
Blogs on Carotid body tumor diagnostic study of choice
Directions to Hospitals Treating Psoriasis
Risk calculators and risk factors for Carotid body tumor diagnostic study of choice

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sahar Memar Montazerin, M.D.[2]

Overview

Diagnostic Study of Choice

Study of choice

Angiography is the gold standard test for the diagnosis of carotid body tumor. This investigation provides detailed information on the size, anatomic location, and local invasion on vascular structures of the tumor as well as the presence of atherosclerotic disease which may complicate vascular reconstruction during the time of surgery.^[1]

CT scan with intravenous administration of contrast can also provide useful information on the tumor size and its anatomic location, particularly in case of small lesions.
MR angiography may be used as a non-invasive alternative for patients with small lesions.

Diagnostic results

The following finding(s) on performing [investigation name] is(are) confirmatory for [disease name]:

[Finding 1]
[Finding 2]

Sequence of Diagnostic Studies

The [name of investigation] must be performed when:

The patient presented with symptoms/signs 1, 2, and 3 as the first step of diagnosis.
A positive [test] is detected in the patient, to confirm the diagnosis.

OR

The various investigations must be performed in the following order:

[Initial investigation]
[2nd investigation]

Name of Diagnostic Criteria

There are no established criteria for the diagnosis of carotid body tumor.
There is no accepted histologic criteria for the diagnosis of malignancy in the carotid body tumor. To confirm malignant transformation of the tumor,

References

↑ Swett C, Makar AB, McMartin KE, Palese M, Tephly TR, Corgier M, Pacheco H, Gailani S, McLimans WF, Mundy GR, Nussbaum A, Roholt O, Zeigel R, Wiesmann UN, DiDonato S, Herschkowitz NN (November 1975). "Outpatient phenothiazine use and bone marrow depression. A report from the drug epidemiology unit and the Boston collaborative drug surveillance program". Arch. Gen. Psychiatry. 32 (11): 1416–8. doi:10.1016/0006-2944(75)90147-7. PMID 978.

[pmid978-1] Swett C, Makar AB, McMartin KE, Palese M, Tephly TR, Corgier M, Pacheco H, Gailani S, McLimans WF, Mundy GR, Nussbaum A, Roholt O, Zeigel R, Wiesmann UN, DiDonato S, Herschkowitz NN (November 1975). "Outpatient phenothiazine use and bone marrow depression. A report from the drug epidemiology unit and the Boston collaborative drug surveillance program". Arch. Gen. Psychiatry. 32 (11): 1416–8. doi:10.1016/0006-2944(75)90147-7. PMID 978.

[1]